In addition, BXM also significantly reduced virus titers in the lungs of mice, whereas OSP treatment had limited effect (Fig. 4c), consistent with the prior results from the 10.4 MLD50 infection model (Fig. 2). The gene discussed is CLDN11; the disease is infection.